Psychopharmacology
Looking for contact hours in pharmacology? These podcasts, recorded from recent live conferences, provide cutting-edge clinical updates and are eligible for psychopharmacology contact hours.
W102-19: Psychopharmacology for Persons with Alzheimer's and Other Dementias
Contains 5 Component(s), Includes CreditsPresenter: Pierre Tariot, MD 1.5 pharmacology contact hours
W103-19: Ethical Decision-Making in Mental Health & Psychopharmacology
Contains 5 Component(s), Includes CreditsPresenters: Mindy B. Zeitzer, PhD, MBE, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN 1.25 contact hours
3011-18: Mini Concurrent Sessions: Pharmacology
Contains 5 Component(s), Includes CreditsPresenters: Tammie Gainey, PhD, APRN, FNP-BC, PMHNP-BC; Steven L. Baumann, APRN, NP 0.5 pharmacology contact hours
2011-18: When the Medication Rules Don't Fit: Minimizing Delirium Risk for Older Adults in Integrated Primary Care
Contains 5 Component(s), Includes CreditsPresenter: Pamela R. Stover, DNP, ARNP, PMHNP-BC 0.75 contact hours (0.5 in pharmacology)
2021-18: Breaking Down Barriers: Increasing Access to Psychiatric Medications
Contains 5 Component(s), Includes CreditsPresenter: Judy A. Rice, DNP, PMHNP-BC, FNP-BC 0.75 pharmacology contact hours
2031-18: From Immediate Release to Long Acting, Drug Delivery Systems: What Do They Mean & Why Do They Matter?
Contains 5 Component(s), Includes CreditsPresenter: Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP 0.5 pharmacology contact hours
1031-18: Mind and Body: Psychotropic Effects on Physiologic Health
Contains 5 Component(s), Includes CreditsPresenter: Alan Tony Amberg, APN, PMHNP-BC 2.0 pharmacology contact hours
1035-18: Trauma-Based Disorders and the Cardio-Neural Mechanisms Involved in Dysfunctional Self-Regulation
Contains 5 Component(s), Includes CreditsPresenters: William Nicholson, MSN, PMHNP-BC, PhD(c); Simone Durand, MSN, PMHNP-BC; Jennifer Carpenter, MSN, PMHNP-BC 2.0 contact hours (0.5 in pharmacology hours)
1041-18: Barriers to the Implementation of Pharmacogenomics in Psychiatric Clinical Practice: An Integrative Review
Contains 5 Component(s), Includes CreditsPresenter: David Nana Ampong, MSN, RN 1.0 pharmacology contact hours
301-18: Naming, Framing, and Containing the Physiology of Fear – A Wellness Approach
Contains 5 Component(s), Includes CreditsPresenter: Mary D. Moller, DNP, PhD, ARNP, PMHCNS-BC, CPRP, FAAN - 1.25 pharmacology contact hours
302-18: Psychotropic Medications & Impact on the Bone
Contains 5 Component(s), Includes CreditsPresenter: Karen L. Houseknecht, PhD - 1.0 pharmacology contact hours
204-18: Shared Decision Making in Pharmacotherapy Management
Contains 5 Component(s), Includes CreditsPresenter: Mary A. Gutierrez, PharmD, BCPP - 1.75 pharmacology contact hours
104-18: Legal Issues in Prescribing
Contains 5 Component(s), Includes CreditsPresenter: Carolyn Buppert, MSN, JD - 1.50 pharmacology contact hours
101-18: Marijuana Science Update
Contains 5 Component(s), Includes CreditsPresenter: Wilson M. Compton, MD, MPE - 1.50 pharmacology contact hours
3022-17: Essential RN Competencies for the Induction and Maintenance of Opioid Replacement Therapy
Contains 5 Component(s), Includes CreditsPresenters: Janet Marie Standard, DNP, PMHNP-BC; Michelle Knapp, DNP, PMHNP-BC 0.75 pharmacology contact hours
2011-17: VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain
Contains 5 Component(s), Includes CreditsPresenter: James Sall, PhD, FNP-BC 0.75 pharmacology contact hours
2031-17: So Many Atypical Antipsychotics How to Choose: The Current Psychopharmacological Treatment Landscape for Psychotic Spectrum Disorders
Contains 5 Component(s), Includes CreditsPresenter: Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP 0.75 pharmacology contact hours
2056-17: Signaling Safety: Interpersonal Interventions and Biological Stress Response; Brain Stimulation and New Advances in ECT - in memory of Mary Rosedale, PhD, PMHNP-BC
Contains 5 Component(s), Includes CreditsPresenters: Rebecca Elizabeth Salomon MSN, PMHNP-BC; Linda Song Beeber, PhD, PMHNCNS-BC, 0.75 contact hours
2051-17: Mini Concurrent Sessions: Psychopharmacology
Contains 5 Component(s), Includes CreditsPresenters: Deborah Salani DNP, PMHNP-BC, NE-BC; Leigh A. Minchew DNP, APRN, WHNP-BC 0.75 pharmacology CE
1037-17: The Match Game: Matching Antidepressants to Symptoms of Anxiety and Depression--Which Drug for Which Symptom?
Contains 5 Component(s), Includes CreditsPresenter: Mary D. Moller DNP, ARNP, PMHCNS-BC, CPRP, FAAN 2.0 pharmacology contact hours
1027-17: Treating Tobacco & Nicotine Dependence: How Your Assumptions About Treatment Can Undermine Your Delivery of Care
Contains 5 Component(s), Includes CreditsPresenter: Carol Essenmacher PMHCNS-BC, DNP, CTTS 2.0 pharmacology contact hours
1017-17: Intersecting Mental Health and Palliative Care: Pharmacologic and Non-pharmacologic Treatment of Life Limiting Illness
Contains 5 Component(s), Includes CreditsPresenter: Mark A. Curtis MSN, PMHCNS-BC, ACHPN, LMT 2.0 contact hours
4011-17: An Introduction to Medication Assisted Treatments for Opiate Use Disorders
Contains 5 Component(s), Includes CreditsPresenter: Mary Weber, PhD, PMHNP-BC, FAANP, FAAN 0.75 pharmacology contact hours
100-18: Paradigm Shift in Treating Mental Illness: Neurophysiological Approach to Prescribing
Contains 5 Component(s), Includes CreditsPresenter: Barbara J. Limandri, PhD, PMHCNS-BC - 1.50 pharmacology contact hours
102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions
Contains 5 Component(s), Includes CreditsPresenters: Wendy A. Henderson, PhD, MSN, CRNP, FAAN; Lorenzo Leggio, MD, PhD, MSc - 1.75 pharmacology contact hours
105-18: What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium
Contains 5 Component(s), Includes CreditsPresenter: Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC 1.25 pharmacology contact hours
Effective Treatments for Opioid Use Disorder: Educating & Empowering Advanced Practice Registered Nurses (APRN) During an Epidemic
Contains 15 Component(s), Includes CreditsThis continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding the epidemic of opioid use in the U.S. and to answer the question, “What can nurses do?” to address this growing problem. Almost 4 million nurses can make a difference!
1015-17: Treating Nicotine and Tobacco Dependence: Assumptions That Could be Harmful to Your Patients
Contains 5 Component(s), Includes CreditsPresenter: Carol Essenmacher, PMHCNS-BC, DNP, CTTS 1.25 pharmacology contact hours
1011-17: Optimizing the Aging Journey: Psychopharmacologic Approaches to Geriatric Anxiety, Depression, Delirium and Dementia
Contains 5 Component(s), Includes CreditsPresenter: Grace Nadolny, MD 1.5 pharmacology contact hours
1008-17: The Management of Mood and Anxiety Disorders in Pregnancy and Postpartum
Contains 5 Component(s), Includes CreditsPresenter: Lauren M. Osborne, MD 1.5 pharmacology contact hours
1010-17: Employing Multiple Mechanisms with Downstream Effects: Contemporary Psychopharmacologic Approaches
Contains 5 Component(s), Includes CreditsPresenter: Christian J. Teter, PharmD, BCPP 1.25 pharmacology contact hours
1003-17: Clinical Treatment Targets in Addictions
Contains 5 Component(s), Includes CreditsPresenter: Lorenzo Leggio, MD, PhD, MSc 1.5 pharmacology contact hours
1001-17: The Power of Zzzzs: Sleep Solutions for Psychiatric Nursing Practice
Contains 5 Component(s), Includes CreditsPresenter: Joseph M. Holshoe, MSN, PMHNP-BC 2.0 pharmacology contact hours
APNA Transitions in Practice Certificate Program
Contains 31 Component(s), Includes CreditsThe APNA Transitions in Practice (ATP) Certificate Program has been developed to provide and improve the foundational knowledge of RNs and is presented by recognized expert leaders in the PMH nursing field. The program focuses on best practices and evidence-based nursing knowledge that will optimize success in nursing practice and improve healthcare outcomes for persons with mental health disorders.
1025-16: Risk Management Considerations When Prescribing Controlled Substances
Contains 5 Component(s), Includes CreditsPresenters: Moira K. Wertheimer, Esq., RN, CPHRM 1.5 pharmacology contact hours
1014-16: T-3 + T-4: Do You Know Your Patient's Score? The Role of Thyroid Hormones in the Management of Depression
Contains 5 Component(s), Includes Credits Recorded On: 06/12/2016Presenter: Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN 1.5 contact hours
1008-16: Treating Opioid Use Disorder During the Current Epidemic
Contains 5 Component(s), Includes Credits Recorded On: 06/11/2016Presenter: Matthew Tierney, APN-BC, PMHNP-BC 1.5 contact hours
1013-16: Tobacco Dependence Treatment: Neurobiology through Public Policy
Contains 5 Component(s), Includes Credits Recorded On: 06/11/2016Presenter: Mary Ellen Wewers, PhD, RN 1.25 contact hours
1005-16: Military Psychiatry: Practice and Pitfalls for Civilian Providers
Contains 5 Component(s), Includes Credits Recorded On: 06/10/2016Presenter: Joseph Holshoe, MSN, PMHNP-BC 1.5 contact hours
1006-16: Assessment and Treatment of Transgender and Gender Expansive Youth
Contains 5 Component(s), Includes Credits Recorded On: 06/10/2016Presenter: Valerie Tobin, MS, PMHNP, PMHCNS-BC 1.25 pharmacology contact hours
1002-16: Pharmacologic Treatment of Schizophrenia: How Far Have We Come?
Contains 5 Component(s), Includes Credits Recorded On: 06/10/2016Presenter: John M. Kane, MD 1.5 contact hours
1001-16: Benzodiazepines: Boon or Boondoggle and Counteraction
Contains 5 Component(s), Includes Credits Recorded On: 06/09/2016Presenter: Barbara Limandri, PhD, PMHNP, BC 2.0 contact hours
are registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.